生体吸収性冠動脈ステントの世界市場：市場規模・シェア・動向分析 (材料別・薬剤別・最終用途別・地域別・セグメント別、2025年～2030年)

生体吸収性冠動脈ステント市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の生体吸収性冠動脈ステント市場規模は、2025年から2030年にかけてCAGR 4.1%で拡大し、2030年には2億1,010万米ドルに達する見込みです。

生体吸収性ステントは、主に若年成人を対象としており、これらの人々は、溶解可能なデバイスの完全な吸収後、正常な機能を持つ動脈を使用できるようになります。生活習慣病と関連する危険因子の蔓延が、アテローム性動脈硬化症関連の心臓イベントの成長を支えています。生活習慣病と関連する危険因子の蔓延が、アテローム性動脈硬化症に関連した心臓イベントの増加を支えています。このことが、若年成人における世界の疾患蔓延と、選択的経皮的冠動脈インターベンション (PCI) の多発を後押ししています。

第2世代の生体吸収性冠動脈ステントの特徴は何でしょうか？過去の失敗から学んだメーカーは、ストラットの厚みを薄くし、吸収時間を短縮し、橈骨力を向上させた新世代の生体吸収性ステントを開発しました。アマランス社は、ストラットの厚さに一点集中し、そのようなステントを3種類開発しました。それぞれストラットが薄くなっています。最新のマグニチュードは100ミクロンです。

この市場に活力を与えているもう一つの要因は、冠動脈バイパス移植術に比べてPCIは侵襲性が低いため、選択的手術件数が多いことです。世界のほとんどの地域では、不適切な手術をチェックするための監査が行われていないことが、冠動脈ステント留置術の件数を増加させています。従って、この市場は、特にAPACと欧州における選択的PCI件数の多さから成長が見込まれます。

生体吸収性冠動脈ステント市場レポート・ハイライト

• ポリマーのセグメントは2024年に50.2%の最大市場シェアを占め、金属セグメントは予測期間中に最も速いCAGRで成長すると予測されます。
• シロリムスのセグメントは2024年に63.1%の最大シェアを占め、ノバリムスのセグメントは2025年から2030年にかけて最も速いCAGRで成長すると予測されます。
• 外来施設セグメントは2024年に61.9%の最大市場シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。
• より高い市場シェアを獲得するために各社が取り組んでいる戦略的努力の中心は、生体吸収性冠動脈ステントの開発です。臨床パイプラインをターゲットとする各社は、ゴールドスタンダードである薬剤溶出性金属ステントとの比較可能性を得るために、ストラットの厚みを薄くして吸収速度を速めたデバイスなど、より優れた設計仕様の第2世代の生体吸収性製品を開発しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 生体吸収性冠動脈ステント市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 生体吸収性冠動脈ステント市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • パイプライン分析

第4章 生体吸収性冠動脈ステント市場：材料別の推定と動向分析

• 世界の生体吸収性冠動脈ステント市場：材料別のダッシュボード
• 世界の生体吸収性冠動脈ステント市場：変動分析、材料別
• 世界の生体吸収性冠動脈ステント市場：材料別 (収益ベース)
• ポリマー
• 金属

第5章 生体吸収性冠動脈ステント市場：薬剤別の推定と動向分析

• 世界の生体吸収性冠動脈ステント市場：薬剤別のダッシュボード
• 世界の生体吸収性冠動脈ステント市場：変動分析、薬剤別
• 世界の生体吸収性冠動脈ステント市場：薬剤別 (収益ベース)
• シロリムス
• ノバリムス
• その他

第6章 生体吸収性冠動脈ステント市場：最終用途別の推定と動向分析

• 世界の生体吸収性冠動脈ステント市場：最終用途別のダッシュボード
• 世界の生体吸収性冠動脈ステント市場：変動分析、最終用途別
• 世界の生体吸収性冠動脈ステント市場：最終用途別 (収益ベース)
• 入院施設
• 外来施設

第7章 生体吸収性冠動脈ステント市場：地域別の推定と動向分析 (国別・材料別・薬剤別・最終用途別)

• 地域別ダッシュボード
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最新動向と影響分析：主要メーカー別
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析 (2024年)
• 企業プロファイル
  • Biotronik
  • Meril Life Sciences Pvt. Ltd.
  • Elixir Medical
  • REVA Medical, LLC
  • Arterial Remodeling Technologies SA
  • LifeTech Scientific
  • Microport Scientific Corporation
  • LEPU Medical

List of Tables

• Table 1 List of abbreviations
• Table 2 Global bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 3 Global bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 4 Global bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 5 Global bioresorbable coronary stents market, by region, 2018 - 2030 (USD Million)
• Table 6 North America bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
• Table 7 North America bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 8 North America bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 9 North America bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 11 U.S. bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 12 U.S. bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 14 Canada bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 15 Canada bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 17 Mexico bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 18 Mexico bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 21 Europe bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 22 Europe bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 24 Germany bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 25 Germany bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 26 UK bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 27 UK bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 28 UK bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 29 France bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 30 France bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 31 France bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 33 Italy bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 34 Italy bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 36 Spain bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 37 Spain bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 39 Denmark bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 40 Denmark bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 42 Sweden bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 43 Sweden bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 44 Norway bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 45 Norway bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 46 Norway bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 51 China bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 52 China bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 53 China bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 54 Japan bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 55 Japan bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 56 Japan bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 57 India bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 58 India bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 59 India bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Korea bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 61 South Korea bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 62 South Korea bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 63 Australia bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 64 Australia bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 65 Australia bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 67 Thailand bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 68 Thailand bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 71 Latin America bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 72 Latin America bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 74 Brazil bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 75 Brazil bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 77 Argentina bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 78 Argentina bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 82 South Africa bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 83 South Africa bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 84 South Africa bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 88 UAE bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 89 UAE bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 90 UAE bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
• Table 91 Kuwait bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
• Table 92 Kuwait bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
• Table 93 Kuwait bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Dental chair market segmentation
• Fig. 8 Market snapshot, 2024
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Global Bioresorbable Coronary Stents Market: Material Outlook Key Takeaways
• Fig. 15 Global Bioresorbable Coronary Stents Market: Material Movement Analysis
• Fig. 16 Global Polymer Market, 2018 - 2030 (USD Million)
• Fig. 17 Global Metal Market, 2018 - 2030 (USD Million)
• Fig. 18 Global Bioresorbable Coronary Stents Market: Drug Outlook Key Takeaways
• Fig. 19 Global Bioresorbable Coronary Stents Market: Drug Movement Analysis
• Fig. 20 Global Sirolimus Market, 2018 - 2030 (USD Million)
• Fig. 21 Global Novalimus Market, 2018 - 2030 (USD Million)
• Fig. 22 Global Others Market, 2018 - 2030 (USD Million)
• Fig. 23 Global Bioresorbable Coronary Stents Market: End Use Outlook Key Takeaways
• Fig. 24 Global Bioresorbable Coronary Stents Market: End Use Movement Analysis
• Fig. 25 Global Inpatient Facilities Market, 2018 - 2030 (USD Million)
• Fig. 26 Global Outpatient Facilities Market, 2018 - 2030 (USD Million)
• Fig. 27 Regional Marketplace: Key Takeaways
• Fig. 28 Regional outlook, 2024 & 2030
• Fig. 29 Global Bioresorbable Coronary Stents Market: Region Movement Analysis
• Fig. 30 North America Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 33 Mexico Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 34 Europe Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 35 Germany Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 36 UK Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 37 France Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 38 Italy Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 39 Spain Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 40 Denmark Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 41 Sweden Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 42 Norway Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 43 Asia pacific Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 44 Japan Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 45 China Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 46 India Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 47 Australia Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 48 South Korea Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 49 Thailand Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 52 Argentina Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 53 Middle East and Africa Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 54 South Africa Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 56 UAE Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
• Fig. 58 Strategy framework

Bioresorbable Coronary Stents Market Growth & Trends:

The global bioresorbable coronary stents market size is expected to reach USD 210.1 million by 2030, expanding at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Bioresorbable Coronary Stents Market Report Highlights:

• The polymer segment held the largest market share of 50.2% in 2024 and the metal segment is anticipated to grow at the fastest CAGR over the forecast period.
• The sirolimus segment held the largest market share of 63.1% in 2024 and the Novalimus segment is anticipated to grow at the fastest CAGR from 2025 to 2030.
• The outpatient facilities segment held the largest market share of 61.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
• Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Drug
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material outlook
  • 2.2.2. Drug outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. Bioresorbable Coronary Stents Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Development in biocompatible materials
    • 3.2.1.2. Rising incidence of cardiovascular diseases
    • 3.2.1.3. Advancements in minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High initial cost
    • 3.2.2.2. Material recalls
• 3.3. Bioresorbable Coronary Stents Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. Bioresorbable Coronary Stents Market: Material Estimates & Trend Analysis

• 4.1. Global Bioresorbable Coronary Stents Market: Material Dashboard
• 4.2. Global Bioresorbable Coronary Stents Market: Material Movement Analysis
• 4.3. Global Bioresorbable Coronary Stents Market by Material, Revenue
• 4.4. Polymer
  • 4.4.1. Polymer market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Metal
  • 4.5.1. Metal market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Bioresorbable Coronary Stents Market: Drug Estimates & Trend Analysis

• 5.1. Global Bioresorbable Coronary Stents Market: Drug Dashboard
• 5.2. Global Bioresorbable Coronary Stents Market: Drug Movement Analysis
• 5.3. Global Bioresorbable Coronary Stents Market by Drug, Revenue
• 5.4. Sirolimus
  • 5.4.1. Sirolimus market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Novalimus
  • 5.5.1. Novalimus market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Bioresorbable Coronary Stents Market: End Use Estimates & Trend Analysis

• 6.1. Global Bioresorbable Coronary Stents Market: End Use Dashboard
• 6.2. Global Bioresorbable Coronary Stents Market: End Use Movement Analysis
• 6.3. Global Bioresorbable Coronary Stents Market by End Use, Revenue
• 6.4. Inpatient Facilities
  • 6.4.1. Inpatient facilities market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis by Country, Material, Drug and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Biotronik
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Material benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Meril Life Sciences Pvt. Ltd.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Material benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Elixir Medical
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Material benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. REVA Medical, LLC
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Material benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Arterial Remodeling Technologies SA
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Material benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. LifeTech Scientific
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Material benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Microport Scientific Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Material benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. LEPU Medical
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Material benchmarking
    • 8.4.8.4. Strategic initiatives